CompletedNot Applicable

Vascular No-React Graft Against Infection

Netherlands43 participantsStarted 2017-12-22

Plain-language summary

This study seeks to demonstrate the effectiveness and safety of the Non-valved Conduit for CE marking on the basis of infection. The rationale for infection resistance with the conduit is that BioIntegral Surgical No-React® treated products have a well-documented history of infection resistance in hybrid vascular settings.

Who can participate

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Infected prosthetic graft and/or bifurcation * High risk of infection at graft implantation * Mycotic aneurysm * No alternative available Exclusion Criteria: * Below-knee procedure * AV access

What they're measuring

Percentage of graft infection 3 months after implantation

Timeframe: 3 months after implantation

Trial details

NCT IDNCT04031001

SponsorCatharina Ziekenhuis Eindhoven

Sponsor typeOTHER

Study typeOBSERVATIONAL

Primary completion2021-02-06

View on ClinicalTrials.gov More Vascular Infections trials